iSpecimen stock gains on Nasdaq after a firm session
Published on 09/25/2026 at 06:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
iSpecimen stock (ISIN unavailable) stood at USD 1.25 on Nasdaq on September 24, 2026, after a daily gain of 3.31 percent. The move came against a 52-week range of USD 1.21 to USD 58.40, leaving the stock 97.86 percent below the upper end of that span.
Marketplace remains the core asset
iSpecimen describes its platform as an online marketplace connecting life science researchers with patients, human biospecimens and related data. The company says its network includes hospitals, laboratories, biobanks and blood centers, giving researchers access to biofluids, tissues and living cells.
The investor presentation identifies a USD 3 billion to USD 4 billion market opportunity and describes iSpecimen as an early-stage business with a first-mover position. That combination makes operating scale the key financial question for the company, because the marketplace model depends on connecting supply and research demand efficiently.
Growth claims set a high bar
The same investor page cites a 59 percent six-year revenue compound annual growth rate and a 24 percent five-year revenue growth rate. It also describes a growing data asset as a competitive differentiator and says management has more than 100 years of combined experience.
Those figures are company highlights rather than a fresh earnings release. For investors, the comparison between the stated growth rates and the stock's 97.86 percent distance from its 52-week high puts execution at the center of the valuation debate.
Stock trades near yearly low
iSpecimen had a market capitalization of USD 173,578 on September 24, 2026. At USD 1.25, the stock was USD 0.04 above its 52-week low of USD 1.21, while the daily gain of 3.31 percent marked a positive session on Nasdaq.
iSpecimen stock facts
- Company: iSpecimen Inc.
- Ticker: ISPC
- Trading venue: Nasdaq
- Price as of September 24, 2026: USD 1.25
- Market capitalization: USD 173,578 as of September 24, 2026
- 52-week range: USD 1.21-USD 58.40
- Sector / Industry: Healthcare / Medical Diagnostics and Research
